Abridge

Overview
Activities
News
Telehealth?
Hospital Management?
Generative AI Applications?
Product stageSegments
Early
?
Technology Service Providers
?

Abridge is an AI-focused company that provides automated note-taking solutions for healthcare providers. It uses its medical conversation AI, a dataset of 1.5 million medical encounters, and peer-reviewed research to provide this solution. As of August 2022, Abridge has worked with over 2,000 clinicians and 200,000 patients. The company also has several current and upcoming partnerships with healthcare providers across the value chain from payers to pharmacies to Fortune 5 healthcare companies.


Key customers and partnerships

In March 2024, Abridge partnered with not-for-profit health system Sutter Health, to implementing Abridge’s AI platform for clinical documentation across Sutter's network in California.

In June 2024, Abridge partnered with The University of Vermont Health Network to improve clinician well-being. Through the partnership, Abridge's AI-powered platform was deployed across the university’s health network to generate clinical notes from patient-clinician conversations in real-time. The company noted that the enterprise-wide rollout would initially cover primary care and later expand to specialties like cardiology and endocrinology.

Most recently in July 2024, the company partnered with health IT giant Epic and healthcare system Mayo Clinic to create a GenAI documentation platform. The partnership aimed to integrate Abridge's AI transcription and documentation tools into Epic's EHR workflow for Mayo Clinic's nurses. The GenAI tool utilized Abridge's technology to automatically transcribe and summarize conversations between nurses and patients while leveraging Epic's expertise in EHR integration and Mayo Clinic's knowledge of nursing practices.


Funding and financials

In February 2024 Abridge raised USD 150 million in a Series C funding round co-led by Lightspeed Venture Partners and Redpoint Ventures. This brought the company's valuation to around USD 850 million. The raised capital was set aside for recruitment and the acquisition and training of bespoke medical AI models.


HQ location:
500 Grant Street Suite 2900 Pittsburgh PA USA
Founded year:
2018
Employees:
51-100
IPO status:
Private
Total funding:
USD 207.5 mn
Last Funding:
USD 150.0 mn (Series C; Feb 2024)
Last valuation:
USD 850.0 mn (Feb 2024)
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.